Literature DB >> 18372789

The GNAS locus and pseudohypoparathyroidism.

Murat Bastepe1.   

Abstract

Pseudohypoparathyroidism (PHP) is a disorder of end-organ resistance primarily affecting the actions of parathyroid hormone (PTH). Genetic defects associated with different forms of PHP involve the alpha-subunit of the stimulatory G protein (Gsalpha), a signaling protein essential for the actions of PTH and many other hormones. Heterozygous inactivating mutations within Gsalpha-encoding GNAS exons are found in patients with PHP-Ia, who also show resistance to other hormones and a constellation ofphysical features called Albright's hereditary osteodystrophy (AHO). Patients who exhibit AHO features without evidence for hormone resistance, who are said to have pseudopseudohypoparathyroidism (PPHP), also carry heterozygous inactivating Gsalpha mutations. Maternal inheritance of such a mutation leads to PHP-Ia, i.e., AHO plus hormone resistance, while paternal inheritance of the same mutation leads to PPHP, i.e., AHO only. This imprinted mode of inheritance for hormone resistance can be explained by the predominantly maternal expression of Gsalpha in certain tissues, including renal proximal tubules. Patients with PHP-Ib lack coding Gsalpha mutations but display epigenetic defects of the GNAS locus, with the most consistent defect being a loss of imprinting at the exon A/B differentially methylated region (DMR). This epigenetic defect presumably silences, in cis, Gsalpha expression in tissues where this protein is derived from the maternal allele only, leading to a marked reduction of Gsa levels. The familial form of PHP-Ib (AD-PHP-Ib) is typically associated with an isolated loss of imprinting at the exon A/B DMR. A unique 3-kb microdeletion that disrupts the neighboring STX16 1ocus has been identified in this disorder and appears to be the cause of the loss of imprinting. In addition, deletions removing the entire NESP55 DMR, located within GNAS, have been identified in some AD-PHP-Ib kindreds in whom affected individuals show loss of all the maternal GNAS imprints. Mutations identified in different forms of PHP-Ib thus point to different cis-acting elements that are apparently required for the proper imprinting of the GNAS locus. Most sporadic PHP-Ib cases also have imprinting abnormalities of GNAS that involve multiple DMRs, but the genetic lesion(s) responsible for these imprinting abnormalities remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372789     DOI: 10.1007/978-0-387-77576-0_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  34 in total

1.  Recessive versus imprinted disorder: consanguinity can impede establishing the diagnosis of autosomal dominant pseudohypoparathyroidism type Ib.

Authors:  Serap Turan; Leyla Akin; Teoman Akcay; Erdal Adal; Sevil Sarikaya; Murat Bastepe; Harald Jüppner
Journal:  Eur J Endocrinol       Date:  2010-06-10       Impact factor: 6.664

2.  Falling too Fahr.

Authors:  Arianna Merlini; Luca Peruzzotti-Jametti; Marco Bacigaluppi; Giovanna Mantovani; Annamaria Spada; Mariaemma Rodegher; Giancarlo Comi
Journal:  J Neurol       Date:  2012-01-21       Impact factor: 4.849

3.  Unbalanced der(5)t(5;20) translocation associated with megalencephaly, perisylvian polymicrogyria, polydactyly and hydrocephalus.

Authors:  Annemieke J M H Verkerk; Rachel Schot; Laura van Waterschoot; Hannie Douben; Pino J Poddighe; Maarten H Lequin; Linda S de Vries; Paulien Terhal; Johanne M D Hahnemann; Irenaeus F M de Coo; Marie-Claire Y de Wit; Leontien S Wafelman; Livia Garavelli; William B Dobyns; Peter J Van der Spek; Annelies de Klein; Grazia M S Mancini
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

4.  Madelung-like deformity in pseudohypoparathyroidism type 1b.

Authors:  Janine Sanchez; Erasmo Perera; Suzanne Jan de Beur; Changlin Ding; Anna Dang; Gary D Berkovitz; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

5.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

6.  Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism.

Authors:  Svetlana Puzhko; Cynthia Gates Goodyer; Mohammad Amin Kerachian; Lucie Canaff; Madhusmita Misra; Harald Jüppner; Murat Bastepe; Geoffrey N Hendy
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

Review 7.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 8.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

9.  Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B).

Authors:  Rieko Takatani; Masanori Minagawa; Angelo Molinaro; Monica Reyes; Kaori Kinoshita; Tomozumi Takatani; Itsuro Kazukawa; Misako Nagatsuma; Kenichi Kashimada; Kenichi Sato; Kazuyuki Matsushita; Fumio Nomura; Naoki Shimojo; Harald Jüppner
Journal:  Bone       Date:  2015-05-19       Impact factor: 4.398

10.  Clinical utility gene card for: pseudohypoparathyroidism.

Authors:  Giovanna Mantovani; Agnes Linglart; Intza Garin; Caroline Silve; Francesca M Elli; Guiomar Perez de Nanclares
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.